Editorial: Identifying novel biomarkers in bladder cancer.
作者信息
Ecke Thorsten H, Lotan Yair, Massfelder Thierry
机构信息
Department of Urology, Helios Hospital Bad, Saarow, Germany.
Deparment of Urology, Universitätsmedizin Berlin Charité, Berlin, Germany.
出版信息
Front Oncol. 2023 Jul 4;13:1191736. doi: 10.3389/fonc.2023.1191736. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Identifying novel biomarkers in bladder cancer.社论：识别膀胱癌中的新型生物标志物。
Front Oncol. 2023 Jul 4;13:1191736. doi: 10.3389/fonc.2023.1191736. eCollection 2023.
2
Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer.尿液外泌体mRNA和lncRNA联合作为膀胱癌新型诊断生物标志物
Front Oncol. 2021 Apr 27;11:667212. doi: 10.3389/fonc.2021.667212. eCollection 2021.
3
Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.拉曼化学尿液分析（Rametrix）作为膀胱癌的筛查手段。
PLoS One. 2020 Aug 21;15(8):e0237070. doi: 10.1371/journal.pone.0237070. eCollection 2020.
4
Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method.基于新型逆转录-端粒重复扩增-2聚合酶链反应法检测尿液和组织端粒酶活性诊断尿路上皮膀胱癌
J Clin Med. 2021 Mar 4;10(5):1055. doi: 10.3390/jcm10051055.
5
Bladder cancer risk stratification using a urinary mRNA biomarker panel - A path towards cystoscopy triaging.基于尿液 mRNA 生物标志物panel 的膀胱癌风险分层——一种用于膀胱镜分诊的策略。
Urol Oncol. 2021 Aug;39(8):497.e9-497.e15. doi: 10.1016/j.urolonc.2021.02.011. Epub 2021 Mar 22.
6
Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.尿液 DNA 甲基化检测可实现膀胱癌的早期检测和复发监测。
J Clin Invest. 2020 Dec 1;130(12):6278-6289. doi: 10.1172/JCI139597.
7
Identification and validation of methylated PENK gene for early detection of bladder cancer using urine DNA.利用尿液DNA鉴定和验证甲基化的PENK基因用于膀胱癌的早期检测
BMC Cancer. 2022 Nov 19;22(1):1195. doi: 10.1186/s12885-022-10275-2.
8
Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.用于诊断移行性膀胱癌的高灵敏度和高特异性新型生物标志物。
Oncotarget. 2015 May 30;6(15):13539-49. doi: 10.18632/oncotarget.3841.
9
Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.尿代谢物变化的研究及其在膀胱癌生物标志物发现中的应用。
Int J Cancer. 2018 Jul 15;143(2):408-418. doi: 10.1002/ijc.31323. Epub 2018 Mar 2.
10
Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: A comparative prospective study.MCM5（ADXBLADDER）分析在男性膀胱癌初始诊断评估中的预测价值：一项比较性前瞻性研究。
Diagn Cytopathol. 2020 Nov;48(11):1034-1040. doi: 10.1002/dc.24530. Epub 2020 Jun 20.
本文引用的文献
1
A novel strategy for treatment of bladder cancer: Antibody-drug conjugates.一种治疗膀胱癌的新策略：抗体药物偶联物。
Investig Clin Urol. 2022 Jul;63(4):373-384. doi: 10.4111/icu.20220061. Epub 2022 May 30.
2
Nomograms including the UBC Rapid test to detect primary bladder cancer based on a multicentre dataset.基于多中心数据集的包含UBC快速检测法的列线图用于检测原发性膀胱癌。
BJU Int. 2022 Dec;130(6):754-763. doi: 10.1111/bju.15677. Epub 2022 Jan 11.
3
Identifying the Molecular Mechanisms Contributing to Progression, Metastasis, and Death in Low-grade Non-muscle-invasive Bladder Cancer: A Case Report.低度非肌层浸润性膀胱癌进展、转移及死亡相关分子机制的鉴定：一例报告
Eur Urol Open Sci. 2021 Mar 18;27:29-32. doi: 10.1016/j.euros.2021.02.006. eCollection 2021 May.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.厄达替尼治疗局部晚期或转移性尿路上皮癌。
N Engl J Med. 2019 Jul 25;381(4):338-348. doi: 10.1056/NEJMoa1817323.
6
The Paris System for Reporting Urinary Cytology: the quest to develop a standardized terminology.巴黎尿细胞学报告系统：开发标准化术语的探索
J Am Soc Cytopathol. 2016 May-Jun;5(3):177-188. doi: 10.1016/j.jasc.2016.04.005. Epub 2016 Apr 19.
7
Molecular Subtypes of Bladder Cancer.膀胱癌的分子亚型。
Curr Oncol Rep. 2018 Aug 20;20(10):77. doi: 10.1007/s11912-018-0727-5.
8
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.肌层浸润性膀胱癌的综合分子特征分析
Cell. 2017 Oct 19;171(3):540-556.e25. doi: 10.1016/j.cell.2017.09.007. Epub 2017 Oct 5.
9
Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer.尿细胞学及其他膀胱癌尿液生物标志物的敏感性和特异性的前瞻性分析。
Urol Oncol. 2015 Feb;33(2):66.e25-31. doi: 10.1016/j.urolonc.2014.06.008. Epub 2014 Jul 15.
10
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.鉴定具有不同一线化疗敏感性的浸润性膀胱癌的基底和腔面亚型。
Cancer Cell. 2014 Feb 10;25(2):152-65. doi: 10.1016/j.ccr.2014.01.009.
Zotero 插件